The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computer assertion could be determined for this classification!


Variant: NM_000536.4(RAG2):c.328A>C (p.Met110Leu)

CA214221

36720 (ClinVar)

Gene: RAG2
Condition: recombinase activating gene 2 deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: cb3e3eda-44e4-4e9c-99b8-f08c01e01d89
Approved on: 2024-05-13
Published on: 2024-05-13

HGVS expressions

NM_000536.4:c.328A>C
NM_000536.4(RAG2):c.328A>C (p.Met110Leu)
NC_000011.10:g.36593841T>G
CM000673.2:g.36593841T>G
NC_000011.9:g.36615391T>G
CM000673.1:g.36615391T>G
NC_000011.8:g.36571967T>G
NG_007573.1:g.9396A>C
NG_033154.1:g.4349T>G
ENST00000527033.6:c.328A>C
ENST00000529083.2:c.328A>C
ENST00000532616.2:c.328A>C
ENST00000311485.8:c.328A>C
ENST00000311485.7:c.328A>C
ENST00000524423.1:n.131+4261A>C
ENST00000529083.1:c.328A>C
ENST00000618712.4:c.328A>C
NM_000536.3:c.328A>C
NM_001243785.1:c.328A>C
NM_001243786.1:c.328A>C
NM_001243785.2:c.328A>C
NM_001243786.2:c.328A>C
More

Uncertain Significance

Met criteria codes 2
PM1_Supporting PM2_Supporting
Not Met criteria codes 3
PP4 PM5 PS3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Severe Combined Immunodeficiency Disease Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for RAG2 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Severe Combined Immunodeficiency Disease VCEP
The c.328A>C (NM_000536.4) variant in RAG2 is a missense variant predicted to cause the substitution of Methionine by Leucine at amino acid 110 (p.Met110Leu). The filtering allele frequency (the upper threshold of the 95% CI of 7/1180032 alleles) of the c.328A>C variant in RAG2 is 0.000001940 for European (non-Finnish) chromosomes by gnomAD v4, which is lower than the ClinGen SCID VCEP threshold (<0.0000588) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting). This variant is located in the core domain, amino acids 1-383 of RAG2, which is defined as a critical functional domain by the ClinGen SCID VCEP (PMID: 26996199); PM1_Supporting. The variant has a mean recombination activity of 74.6% (SEM 1.8) compared to WT hRAG2, which is higher than 60% of wild-type activity (to be considered at least a supporting level). So, PS3 is not applied at any strength level. (PMID: 29772310). At least one patient in the literature seems to be a carrier of this variant (PMID: 29772310); however, the complete genetic and clinical information for the patient is not available. PP4 is not met. In summary, this variant meets the criteria to be classified as a variant of uncertain significance for autosomal recessive recombinase activating gene 2 deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen SCID VCEP: PM2_Supporting and PM1_Supporting (VCEP specifications version 1).
Met criteria codes
PM1_Supporting
This variant is located in the core domain, amino acids 1-383 of RAG2, which is defined as a critical functional domain by the ClinGen SCID VCEP (PMID: 26996199); PM1_Supporting.
PM2_Supporting
The filtering allele frequency (the upper threshold of the 95% CI of 7/1180032 alleles) of the c.328A>C variant in RAG2 is 0.000001940 for European (non-Finnish) chromosomes by gnomAD v4, which is lower than the ClinGen SCID VCEP threshold (<0.0000588) for PM2_Supporting, and therefore meets this criterion (PM2_Supporting).
Not Met criteria codes
PP4
At least one patient in the literature seems to be a carrier of this variant (PMID: 29772310); however, the complete genetic and clinical information for the patient is not available. PP4 is not met.
PM5
A different missense variant in the same codon: c.328A>G (p.Met110Val) has been reported in ClinVar as a Variant of Uncertain Significance; However, this variant has not yet been classified according to the SCID VCEP specifications; so PM5 is not met at any level of the evidence at this moment.
PS3
The variant has a mean recombination activity of 74.6% (SEM 1.8) compared to WT hRAG2, which is higher than 60% of wild-type activity (to be considered at least supporting level). So, PS3 is not applied at any level of strength. (PMID: 29772310, PS3_notmet).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.